Evolent Health, Inc. (EVH): R&D Expense
Older than the company's other figures. The latest R&D Expense is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$15.50M
Year ended 2021-12-31
-5.2%
3-year compound annual growth
+6.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $15.50M | +2.6% | 2022-02-24, From 2021-01-01 |
| 2020-12-31 | $15.10M | -23.7% | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | $19.80M | +8.8% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $18.20M | +5.8% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $17.20M | +55.0% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $11.10M | +91.4% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $5.80M | n/a | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $0 | -100.0% | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | $2.00M | n/a | 2016-02-29, From 2013-01-01 |